NEUROTECH

Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseasesâ€”including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.

#SimilarOrganizations #People #Financial #Event #Website #More

NEUROTECH

Social Links:

Linkedin

Industry:

Biotechnology Medical Therapeutics

Founded:

1995-01-01

Address:

Lincoln, Rhode Island, United States

Country:

United States

Website Url:

http://www.neurotechpharmaceuticals.com

Total Employee:

11+

Status:

Active

Contact:

401-333-3880

Email Addresses:

[email protected]

Total Funding:

49.13 M USD

Technology used in webpage:

SPF Google Font API Google Maps Microsoft Azure DNS GStatic Google Static Content Google Maps API Network Solutions DNS IIS 7 GoDaddy CDN Mimecast

Similar Organizations

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Advisors List

david-guyer_image

David Guyer Board of Directors @ Neurotech
Board_member

Current Employees Featured

thomas-aaberg_image

Thomas Aaberg
Thomas Aaberg Chief Medical Officer (CMO) @ Neurotech
Chief Medical Officer (CMO)
2021-01-01

not_available_image

Richard Small
Richard Small Chief Executive Officer & Board Member @ Neurotech
Chief Executive Officer & Board Member

Investors List

burrill-co_image

Burrill & Company

Burrill & Company investment in Series B - Neurotech

avida-group_image

Triginta Capital

Triginta Capital investment in Series B - Neurotech

mayflower_image

Mayflower

Mayflower investment in Series B - Neurotech

pound-capital_image

Pound Capital

Pound Capital investment in Series B - Neurotech

omega-funds_image

Omega Funds

Omega Funds investment in Series B - Neurotech

excalibur-fund-managers_image

Excalibur Fund Managers

Excalibur Fund Managers investment in Series B - Neurotech

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series B - Neurotech

nexus-medical-partners_image

Nexus Medical Partners

Nexus Medical Partners investment in Series B - Neurotech

apax-partners_image

Apax Partners

Apax Partners investment in Series B - Neurotech

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - Neurotech

Key Employee Changes

Date	New article
2021-11-01	Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer

Official Site Inspections

http://www.neurotechpharmaceuticals.com

Host Informations
Whois Informations

Loading ...

More informations about "Neurotech" on Search Engine